BRCAPAP: Feasibility of clinical BRCA testing on liquid-based cervical cytology: Implications for biomarker development

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 9, 2004, Pages 1534-1537

  Muller, Carolyn Y ^a   Schorge, John O ^a   Tomlinson, Gail E ^a   Ashfaq, Raheela ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC TEST; DNA ISOLATION; FEASIBILITY STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GENOTYPE; GERM LINE; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VAGINA CYTOLOGY;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA MUTATIONAL ANALYSIS; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC COUNSELING; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 4444248767     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185: 308-17.
2. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
3. Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CY. Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000;183:39-45.
4. Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417-25.
5. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20: 1480-90.